The goal of this clinical research study is to learn if giving carboplatin and
paclitaxel after standard therapy for locally advanced cervical cancer can help
to control the disease for a longer time than the standard therapy alone. The
standard therapy is radiation therapy combined with the chemotherapy drug
cisplatin (chemo-radiation). The safety of the combination treatment will also
be studied.

Cisplatin is designed to poison the cancer cells, which may cause them to die.

Carboplatin and paclitaxel are designed to block cancer cells from dividing,
which may cause them to die.

Radiation therapy is designed to kill cancer cells by damaging their DNA
(genetic material).